Investors /

HealthCap

HealthCap is a European venture capital firm specializing in life sciences, with a focus on investing in breakthrough therapies for diseases with high unmet medical needs. Since its founding in 1996, HealthCap has raised eight funds and has been instrumental in backing and building over 130 companies, leading to more than 45 public offerings and numerous trade sales. The firm is dedicated to fostering innovation in healthcare, aiming to make a significant impact on patient outcomes and societal health.

HealthCap

HealthCap

Portfolio

Oncorena

Oncorena received FDA approval to initiate studies in the US.

#Pharmaceuticals

Aprea Therapeutics

Aprea Therapeutics is exploring APR-1051 as a potential treatment for head and neck squamous cell carcinoma.

#Biotechnology

Oncopeptides

Oncopeptides received its first order of Pepaxti in Italy.

#Pharmaceuticals

HelloBetter

HelloBetter secured over €6 million to accelerate international expansion and AI development.

#Digital Health

Hemab Therapeutics

Hemab Therapeutics announced the start of a Phase 1/2 clinical trial for HMB-002 for the treatment of Von Willebrand Disease.

#Biotechnology

Vicore Pharma

Vicore Pharma published its year-end report for 2024.

#Pharmaceuticals

Adcendo ApS

Adcendo ApS focuses on developing breakthrough antibody-drug conjugates for cancer treatment and has raised significant funding to advance its pipeline.

#Biotechnology

Show Less